Status:
COMPLETED
Brain Stimulation for Neurological Patients
Lead Sponsor:
Storz Medical AG
Collaborating Sponsors:
Medical University of Vienna
Conditions:
Alzheimer Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective double-blind randomized placebo-controlled crossover clinical trial
Eligibility Criteria
Inclusion
- Clinically stable patients with probable Alzheimer's Disease (Diagnosis according to ICD-10 Criteria (F00))
- At least 3 months of stable antidementive therapy or no antidementive therapy necessary
- Signed written informed consent
- Monthly pregnancy test for women in childbearing years
- Age \>= 18 years
Exclusion
- Non-compliance with the protocol
- Pregnant or breastfeeding women
- Relevant intracerebral pathology unrelated to the Alzheimers's disease (e.g. Brain tumor)
- Hemophilia or other blood clotting disorders
- Cortisone treatment within the last 6 weeks before first treatment
- Thrombosis
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03770182
Start Date
January 1 2017
End Date
July 27 2022
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria